486 related articles for article (PubMed ID: 24079059)
1. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.
Somech R; Lev A; Simon AJ; Korn D; Garty BZ; Amariglio N; Rechavi G; Almashanu S; Zlotogora J; Etzioni A
Isr Med Assoc J; 2013 Aug; 15(8):404-9. PubMed ID: 24079059
[TBL] [Abstract][Full Text] [Related]
2. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls.
Şentürk G; Ng YY; Eltan SB; Başer D; Ogulur I; Altındirek D; Fırtına S; Yılmaz H; Kocamış B; Kıykım A; Camcıoğlu Y; Ar MC; Sudutan T; Beken S; Temel ŞG; Alanay Y; Karakoc-Aydiner E; Barış S; Özen A; Özbek U; Sayitoğlu M; Hatırnaz Ng Ö
Scand J Immunol; 2022 Mar; 95(3):e13130. PubMed ID: 34951041
[TBL] [Abstract][Full Text] [Related]
3. Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.
Barbaro M; Ohlsson A; Borte S; Jonsson S; Zetterström RH; King J; Winiarski J; von Döbeln U; Hammarström L
J Clin Immunol; 2017 Jan; 37(1):51-60. PubMed ID: 27873105
[TBL] [Abstract][Full Text] [Related]
4. The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome.
Froňková E; Klocperk A; Svatoň M; Nováková M; Kotrová M; Kayserová J; Kalina T; Keslová P; Votava F; Vinohradská H; Freiberger T; Mejstříková E; Trka J; Sedivá A
PLoS One; 2014; 9(12):e114514. PubMed ID: 25485546
[TBL] [Abstract][Full Text] [Related]
5. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
Front Immunol; 2020; 11():1948. PubMed ID: 33178177
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndrome.
Lingman Framme J; Borte S; von Döbeln U; Hammarström L; Oskarsdóttir S
J Clin Immunol; 2014 May; 34(4):514-9. PubMed ID: 24610337
[TBL] [Abstract][Full Text] [Related]
7. Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review.
Shinwari K; Bolkov M; Tuzankina IA; Chereshnev VA
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(2):132-149. PubMed ID: 32748762
[TBL] [Abstract][Full Text] [Related]
8. Establishing Simultaneous T Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) Quantification Assays and Laboratory Reference Intervals in Healthy Individuals of Different Age Groups in Hong Kong.
Kwok JSY; Cheung SKF; Ho JCY; Tang IWH; Chu PWK; Leung EYS; Lee PPW; Cheuk DKL; Lee V; Ip P; Lau YL
Front Immunol; 2020; 11():1411. PubMed ID: 32765500
[TBL] [Abstract][Full Text] [Related]
9. TREC/KREC Newborn Screening followed by Next-Generation Sequencing for Severe Combined Immunodeficiency in Japan.
Wakamatsu M; Kojima D; Muramatsu H; Okuno Y; Kataoka S; Nakamura F; Sakai Y; Tsuge I; Ito T; Ueda K; Saito A; Morihana E; Ito Y; Ohashi N; Tanaka M; Tanaka T; Kojima S; Nakajima Y; Ito T; Takahashi Y
J Clin Immunol; 2022 Nov; 42(8):1696-1707. PubMed ID: 35902420
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for severe combined immunodeficiency using a novel and simplified method to measure T-cell excision circles (TREC).
Tagliaferri L; Kunz JB; Happich M; Esposito S; Bruckner T; Hübschmann D; Okun JG; Hoffmann GF; Schulz A; Kappe J; Speckmann C; Muckenthaler MU; Kulozik AE
Clin Immunol; 2017 Feb; 175():51-55. PubMed ID: 27916705
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.
Boyarchuk O; Yarema N; Kravets V; Shulhai O; Shymanska I; Chornomydz I; Hariyan T; Volianska L; Kinash M; Makukh H
Front Immunol; 2022; 13():999664. PubMed ID: 36189201
[TBL] [Abstract][Full Text] [Related]
12. Defining combined immunodeficiency.
Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
[TBL] [Abstract][Full Text] [Related]
13. Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns.
Marakhonov AV; Efimova IY; Mukhina AA; Zinchenko RA; Balinova NV; Rodina Y; Pershin D; Ryzhkova OP; Orlova AA; Zabnenkova VV; Cherevatova TB; Beskorovainaya TS; Shchagina OA; Polyakov AV; Markova ZG; Minzhenkova ME; Shilova NV; Larin SS; Khadzhieva MB; Dudina ES; Kalinina EV; Mudaeva DA; Saydaeva DH; Matulevich SA; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Nurgalieva LR; Saifullina EV; Belyaeva TI; Romanova OS; Voronin SV; Shcherbina A; Kutsev SI
J Clin Immunol; 2024 Apr; 44(4):93. PubMed ID: 38578360
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
Richards S; Pitt J; Choo S
J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
[TBL] [Abstract][Full Text] [Related]
15. Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville.
de Felipe B; Olbrich P; Lucenas JM; Delgado-Pecellin C; Pavon-Delgado A; Marquez J; Salamanca C; Soler-Palacin P; Gonzalez-Granado LI; Antolin LF; Borte S; Neth O
Pediatr Allergy Immunol; 2016 Feb; 27(1):70-7. PubMed ID: 26498110
[TBL] [Abstract][Full Text] [Related]
16. The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.
Quinn J; Orange JS; Modell V; Modell F
Immunol Res; 2020 Feb; 68(1):48-53. PubMed ID: 32128663
[TBL] [Abstract][Full Text] [Related]
17. A Multiplex, Droplet Digital PCR Assay for the Detection of T-Cell Receptor Excision Circles and Kappa-Deleting Recombination Excision Circles.
Profaizer T; Slev P
Clin Chem; 2020 Jan; 66(1):229-238. PubMed ID: 31672859
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program.
Blom M; Pico-Knijnenburg I; Sijne-van Veen M; Boelen A; Bredius RGM; van der Burg M; Schielen PCJI
Clin Immunol; 2017 Jul; 180():106-110. PubMed ID: 28487086
[TBL] [Abstract][Full Text] [Related]
19. Development of a routine newborn screening protocol for severe combined immunodeficiency.
Baker MW; Grossman WJ; Laessig RH; Hoffman GL; Brokopp CD; Kurtycz DF; Cogley MF; Litsheim TJ; Katcher ML; Routes JM
J Allergy Clin Immunol; 2009 Sep; 124(3):522-7. PubMed ID: 19482345
[TBL] [Abstract][Full Text] [Related]
20. Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal guthrie cards.
Morinishi Y; Imai K; Nakagawa N; Sato H; Horiuchi K; Ohtsuka Y; Kaneda Y; Taga T; Hisakawa H; Miyaji R; Endo M; Oh-Ishi T; Kamachi Y; Akahane K; Kobayashi C; Tsuchida M; Morio T; Sasahara Y; Kumaki S; Ishigaki K; Yoshida M; Urabe T; Kobayashi N; Okimoto Y; Reichenbach J; Hashii Y; Tsuji Y; Kogawa K; Yamaguchi S; Kanegane H; Miyawaki T; Yamada M; Ariga T; Nonoyama S
J Pediatr; 2009 Dec; 155(6):829-33. PubMed ID: 19628217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
